4.6 Article

Acute and Delayed Doxorubicin-Induced Myocardiotoxicity Associated with Elevation of Cardiac Biomarkers, Depletion of Cellular Antioxidant Enzymes, and Several Histopathological and Ultrastructural Changes

Related references

Note: Only part of the references are listed.
Review Biology

Update on Biomarkers Associated to Cardioembolic Stroke: A Narrative Review

Ana Catarina Fonseca et al.

Summary: NT-proBNP and BNP are the most widely studied biomarkers for cardioembolic stroke, with NT-proBNP currently being used for patient selection in clinical trials and risk prediction tools. Other biomarkers have limited use in clinical practice due to methodological quality issues. Validation studies for most biomarkers are lacking.

LIFE-BASEL (2021)

Article Physiology

Comparison of exercise training and estrogen supplementation on mast cell-mediated doxorubicin-induced cardiotoxicity

Sukanya Phungphong et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients

Clarissa Ruggeri et al.

HEART FAILURE REVIEWS (2018)

Article Pharmacology & Pharmacy

Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model

M. Fernandez-Chas et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Review Pharmacology & Pharmacy

Molecular mechanism of doxorubicin-induced cardiomyopathy - An update

Kaviyarasi Renu et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

Review Biochemistry & Molecular Biology

Doxorubicin, DNA torsion, and chromatin dynamics

Fan Yang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)

Article Medicine, Research & Experimental

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Yoshihiko Ichikawa et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Cardiac & Cardiovascular Systems

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Yanti Octavia et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)

Article Medical Laboratory Technology

Biomarkers in acute myocardial injury

Devin W. Kehl et al.

TRANSLATIONAL RESEARCH (2012)

Article Pharmacology & Pharmacy

RETRACTED: Rosiglitazone and pioglitazone aggravate doxorubicin-induced cardiomyopathy in Wistar rats

Priyadarshan Saraogi et al.

BIOMEDICINE & PHARMACOTHERAPY (2011)

Editorial Material Biotechnology & Applied Microbiology

Doxorubicin pathways: pharmacodynamics and adverse effects

Caroline F. Thorn et al.

PHARMACOGENETICS AND GENOMICS (2011)

Article Cardiac & Cardiovascular Systems

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment

Maria Volkova et al.

CURRENT CARDIOLOGY REVIEWS (2011)

Review Cardiac & Cardiovascular Systems

Doxorubicin Cardiomyopathy

Kanu Chatterjee et al.

CARDIOLOGY (2010)

Review Biochemistry & Molecular Biology

DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

Yves Pommier et al.

CHEMISTRY & BIOLOGY (2010)

Review Immunology

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

Yi-Wei Zhang et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)

Article Cardiac & Cardiovascular Systems

Acute cardiac functional and morphological changes after Anthracycline infusions in children

Javier Ganame et al.

AMERICAN JOURNAL OF CARDIOLOGY (2007)

Article Hematology

Late cardiotoxicity after treatment for Hodgkin lymphoma

Berthe M. P. Aleman et al.

BLOOD (2007)

Article Cardiac & Cardiovascular Systems

Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis

Kendall B. Wallace

CARDIOVASCULAR TOXICOLOGY (2007)

Article Cardiac & Cardiovascular Systems

DNA damage is an early event in doxorubicin-induced cardiac myocyte death

Thomas L'Ecuyer et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice

XW Liu et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)

Article Toxicology

Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats

E Fadillioglu et al.

JOURNAL OF APPLIED TOXICOLOGY (2004)

Article Multidisciplinary Sciences

Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity

A Aries et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Pharmacology & Pharmacy

Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy

DL Santos et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)

Article Cell Biology

Early changes in myocardial antioxidant enzymes in rats treated with adriamycin

T Li et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)

Article Medicine, Research & Experimental

Effects by doxorubicin on the myocardium are mediated by oxygen free radicals

MF Xu et al.

LIFE SCIENCES (2001)